Abstract
SERP-1 is a secreted serpin (serine-proteinase inhibitor) encoded by myxoma virus, a poxvirus pathogen of rabbits. SERP-1 is required for myxoma-virus virulence, and the purified protein has been shown to possess independent anti-inflammatory activity in animal models of restenosis and antigen-induced arthritis. As an inhibitor of serine proteinases, SERP-1 acts against tissue-type plasminogen activator, urokinase-type plasminogen activator, plasmin, thrombin and Factor Xa. In the present study, examination of SERP-1 glycosylation-site mutants showed that the N-linked glycosylation of Asn(172) was essential for SERP-1 secretion, whereas mutation of Asn(99) decreased secretion efficiency, indicating that N-linked glycosylation plays an essential role in the processing and trafficking of SERP-1. Furthermore, comparison of SERP-1 from wild-type myxoma virus and a virus containing a targeted disruption of the MST3N sialyltransferase locus demonstrated that SERP-1 is specifically modified by this myxoma-virus-encoded sialyltransferase, and is thus the first reported viral protein shown to by modified by a virally encoded glycosyltransferase. Sialylation of SERP-1 by the MST3N gene product creates a uniquely charged species of secreted SERP-1 that is distinct from SERP-1 produced from other eukaryotic expression systems, though this has no apparent effect upon the kinetics of in vitro proteinase inhibition. Rather, the role of viral sialylation of SERP-1 likely relates to masking antigenicity or targeting SERP-1 to specific sites of action in vivo.
Full Text
The Full Text of this article is available as a PDF (251.4 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Barry M., Lee S. F., Boshkov L., McFadden G. Myxoma virus induces extensive CD4 downregulation and dissociation of p56lck in infected rabbit CD4+ T lymphocytes. J Virol. 1995 Sep;69(9):5243–5251. doi: 10.1128/jvi.69.9.5243-5251.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Barry M., McFadden G. Apoptosis regulators from DNA viruses. Curr Opin Immunol. 1998 Aug;10(4):422–430. doi: 10.1016/s0952-7915(98)80116-7. [DOI] [PubMed] [Google Scholar]
- Bergeron J. J., Zapun A., Ou W. J., Hemming R., Parlati F., Cameron P. H., Thomas D. Y. The role of the lectin calnexin in conformation independent binding to N-linked glycoproteins and quality control. Adv Exp Med Biol. 1998;435:105–116. doi: 10.1007/978-1-4615-5383-0_11. [DOI] [PubMed] [Google Scholar]
- Boshkov L. K., Macen J. L., McFadden G. Virus-induced loss of class I MHC antigens from the surface of cells infected with myxoma virus and malignant rabbit fibroma virus. J Immunol. 1992 Feb 1;148(3):881–887. [PubMed] [Google Scholar]
- Crocker P. R., Freeman S., Gordon S., Kelm S. Sialoadhesin binds preferentially to cells of the granulocytic lineage. J Clin Invest. 1995 Feb;95(2):635–643. doi: 10.1172/JCI117708. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hennet T., Chui D., Paulson J. C., Marth J. D. Immune regulation by the ST6Gal sialyltransferase. Proc Natl Acad Sci U S A. 1998 Apr 14;95(8):4504–4509. doi: 10.1073/pnas.95.8.4504. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Jackson R. J., Hall D. F., Kerr P. J. Myxoma virus encodes an alpha2,3-sialyltransferase that enhances virulence. J Virol. 1999 Mar;73(3):2376–2384. doi: 10.1128/jvi.73.3.2376-2384.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kelm S., Schauer R., Crocker P. R. The Sialoadhesins--a family of sialic acid-dependent cellular recognition molecules within the immunoglobulin superfamily. Glycoconj J. 1996 Dec;13(6):913–926. doi: 10.1007/BF01053186. [DOI] [PubMed] [Google Scholar]
- Kopito R. R. ER quality control: the cytoplasmic connection. Cell. 1997 Feb 21;88(4):427–430. doi: 10.1016/s0092-8674(00)81881-4. [DOI] [PubMed] [Google Scholar]
- Kouchi Z., Kinouchi T., Sorimachi H., Ishiura S., Suzuki K. The deletion of the C-terminal tail and addition of an endoplasmic reticulum targeting signal to Alzheimer's amyloid precursor protein change its localization, secretion, and intracellular proteolysis. Eur J Biochem. 1998 Dec 1;258(2):291–300. doi: 10.1046/j.1432-1327.1998.2580291.x. [DOI] [PubMed] [Google Scholar]
- Kowalski J. M., Parekh R. N., Mao J., Wittrup K. D. Protein folding stability can determine the efficiency of escape from endoplasmic reticulum quality control. J Biol Chem. 1998 Jul 31;273(31):19453–19458. doi: 10.1074/jbc.273.31.19453. [DOI] [PubMed] [Google Scholar]
- Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
- Lasky L. A. Selectin-carbohydrate interactions and the initiation of the inflammatory response. Annu Rev Biochem. 1995;64:113–139. doi: 10.1146/annurev.bi.64.070195.000553. [DOI] [PubMed] [Google Scholar]
- Liu Y., Choudhury P., Cabral C. M., Sifers R. N. Oligosaccharide modification in the early secretory pathway directs the selection of a misfolded glycoprotein for degradation by the proteasome. J Biol Chem. 1999 Feb 26;274(9):5861–5867. doi: 10.1074/jbc.274.9.5861. [DOI] [PubMed] [Google Scholar]
- Lomas D. A., Evans D. L., Upton C., McFadden G., Carrell R. W. Inhibition of plasmin, urokinase, tissue plasminogen activator, and C1S by a myxoma virus serine proteinase inhibitor. J Biol Chem. 1993 Jan 5;268(1):516–521. [PubMed] [Google Scholar]
- Lucas A., Liu L., Macen J., Nash P., Dai E., Stewart M., Graham K., Etches W., Boshkov L., Nation P. N. Virus-encoded serine proteinase inhibitor SERP-1 inhibits atherosclerotic plaque development after balloon angioplasty. Circulation. 1996 Dec 1;94(11):2890–2900. doi: 10.1161/01.cir.94.11.2890. [DOI] [PubMed] [Google Scholar]
- Macen J. L., Upton C., Nation N., McFadden G. SERP1, a serine proteinase inhibitor encoded by myxoma virus, is a secreted glycoprotein that interferes with inflammation. Virology. 1993 Aug;195(2):348–363. doi: 10.1006/viro.1993.1385. [DOI] [PubMed] [Google Scholar]
- Maksymowych W. P., Nation N., Nash P., Macen J., Lucas A., McFadden G., Russell A. S. Amelioration of antigen induced arthritis in rabbits treated with a secreted viral serine proteinase inhibitor. J Rheumatol. 1996 May;23(5):878–882. [PubMed] [Google Scholar]
- Mandrell R. E., Griffiss J. M., Macher B. A. Lipooligosaccharides (LOS) of Neisseria gonorrhoeae and Neisseria meningitidis have components that are immunochemically similar to precursors of human blood group antigens. Carbohydrate sequence specificity of the mouse monoclonal antibodies that recognize crossreacting antigens on LOS and human erythrocytes. J Exp Med. 1988 Jul 1;168(1):107–126. doi: 10.1084/jem.168.1.107. [DOI] [PMC free article] [PubMed] [Google Scholar]
- McFadden G., Lalani A., Everett H., Nash P., Xu X. Virus-encoded receptors for cytokines and chemokines. Semin Cell Dev Biol. 1998 Jun;9(3):359–368. doi: 10.1006/scdb.1998.0245. [DOI] [PubMed] [Google Scholar]
- Morgenstern K. A., Sprecher C., Holth L., Foster D., Grant F. J., Ching A., Kisiel W. Complementary DNA cloning and kinetic characterization of a novel intracellular serine proteinase inhibitor: mechanism of action with trypsin and factor Xa as model proteinases. Biochemistry. 1994 Mar 22;33(11):3432–3441. doi: 10.1021/bi00177a037. [DOI] [PubMed] [Google Scholar]
- Morrison J. F., Walsh C. T. The behavior and significance of slow-binding enzyme inhibitors. Adv Enzymol Relat Areas Mol Biol. 1988;61:201–301. doi: 10.1002/9780470123072.ch5. [DOI] [PubMed] [Google Scholar]
- Nakamura M., Kudo T., Narimatsu H., Furukawa Y., Kikuchi J., Asakura S., Yang W., Iwase S., Hatake K., Miura Y. Single glycosyltransferase, core 2 beta1-->6-N-acetylglucosaminyltransferase, regulates cell surface sialyl-Lex expression level in human pre-B lymphocytic leukemia cell line KM3 treated with phorbolester. J Biol Chem. 1998 Oct 9;273(41):26779–26789. doi: 10.1074/jbc.273.41.26779. [DOI] [PubMed] [Google Scholar]
- Nash P., Barrett J., Cao J. X., Hota-Mitchell S., Lalani A. S., Everett H., Xu X. M., Robichaud J., Hnatiuk S., Ainslie C. Immunomodulation by viruses: the myxoma virus story. Immunol Rev. 1999 Apr;168:103–120. doi: 10.1111/j.1600-065x.1999.tb01286.x. [DOI] [PubMed] [Google Scholar]
- Nash P., Whitty A., Handwerker J., Macen J., McFadden G. Inhibitory specificity of the anti-inflammatory myxoma virus serpin, SERP-1. J Biol Chem. 1998 Aug 14;273(33):20982–20991. doi: 10.1074/jbc.273.33.20982. [DOI] [PubMed] [Google Scholar]
- Parodi A. J. Reglucosylation of glycoproteins and quality control of glycoprotein folding in the endoplasmic reticulum of yeast cells. Biochim Biophys Acta. 1999 Jan 6;1426(2):287–295. doi: 10.1016/s0304-4165(98)00130-5. [DOI] [PubMed] [Google Scholar]
- Powell L. D., Varki A. I-type lectins. J Biol Chem. 1995 Jun 16;270(24):14243–14246. doi: 10.1074/jbc.270.24.14243. [DOI] [PubMed] [Google Scholar]
- Ritchie H., Booth N. A. Secretion of plasminogen activator inhibitor 2 by human peripheral blood monocytes occurs via an endoplasmic reticulum-golgi-independent pathway. Exp Cell Res. 1998 Aug 1;242(2):439–450. doi: 10.1006/excr.1998.4118. [DOI] [PubMed] [Google Scholar]
- Rubin H. Serine protease inhibitors (SERPINS): where mechanism meets medicine. Nat Med. 1996 Jun;2(6):632–633. doi: 10.1038/nm0696-632. [DOI] [PubMed] [Google Scholar]
- Sakaguchi M. Eukaryotic protein secretion. Curr Opin Biotechnol. 1997 Oct;8(5):595–601. doi: 10.1016/s0958-1669(97)80035-3. [DOI] [PubMed] [Google Scholar]
- Schreiber M., Rajarathnam K., McFadden G. Myxoma virus T2 protein, a tumor necrosis factor (TNF) receptor homolog, is secreted as a monomer and dimer that each bind rabbit TNFalpha, but the dimer is a more potent TNF inhibitor. J Biol Chem. 1996 Jun 7;271(23):13333–13341. doi: 10.1074/jbc.271.23.13333. [DOI] [PubMed] [Google Scholar]
- Stone S. R., Hermans J. M. Inhibitory mechanism of serpins. Interaction of thrombin with antithrombin and protease nexin 1. Biochemistry. 1995 Apr 18;34(15):5164–5172. doi: 10.1021/bi00015a030. [DOI] [PubMed] [Google Scholar]
- Sujino K., Jackson R. J., Chan N. W., Tsuji S., Palcic M. M. A novel viral alpha2,3-sialyltransferase (v-ST3Gal I): transfer of sialic acid to fucosylated acceptors. Glycobiology. 2000 Mar;10(3):313–320. doi: 10.1093/glycob/10.3.313. [DOI] [PubMed] [Google Scholar]
- Tedder T. F., Steeber D. A., Chen A., Engel P. The selectins: vascular adhesion molecules. FASEB J. 1995 Jul;9(10):866–873. [PubMed] [Google Scholar]
- Timmis K. N., Boulnois G. J., Bitter-Suermann D., Cabello F. C. Surface components of Escherichia coli that mediate resistance to the bactericidal activities of serum and phagocytes. Curr Top Microbiol Immunol. 1985;118:197–218. doi: 10.1007/978-3-642-70586-1_11. [DOI] [PubMed] [Google Scholar]
- Traving C., Schauer R. Structure, function and metabolism of sialic acids. Cell Mol Life Sci. 1998 Dec;54(12):1330–1349. doi: 10.1007/s000180050258. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Upton C., Macen J. L., Wishart D. S., McFadden G. Myxoma virus and malignant rabbit fibroma virus encode a serpin-like protein important for virus virulence. Virology. 1990 Dec;179(2):618–631. doi: 10.1016/0042-6822(90)90129-f. [DOI] [PubMed] [Google Scholar]
- Varki A. Biological roles of oligosaccharides: all of the theories are correct. Glycobiology. 1993 Apr;3(2):97–130. doi: 10.1093/glycob/3.2.97. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Varki A. Sialic acids as ligands in recognition phenomena. FASEB J. 1997 Mar;11(4):248–255. doi: 10.1096/fasebj.11.4.9068613. [DOI] [PubMed] [Google Scholar]
- Zhang J. X., Braakman I., Matlack K. E., Helenius A. Quality control in the secretory pathway: the role of calreticulin, calnexin and BiP in the retention of glycoproteins with C-terminal truncations. Mol Biol Cell. 1997 Oct;8(10):1943–1954. doi: 10.1091/mbc.8.10.1943. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Zinkernagel R. M. Immunology taught by viruses. Science. 1996 Jan 12;271(5246):173–178. doi: 10.1126/science.271.5246.173. [DOI] [PubMed] [Google Scholar]
